Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Widhalm G et al. – The data indicate that MIB–1 LI in nonfunctioning pituitary adenomas is a clinically useful prognostic parameter indicating probability of progression of postoperative tumor remnants. The MIB–1 LI may be helpful in decisions of postoperative disease management (for example, frequency of radiographic intervals, planning for reoperation, radiotherapy, and/or radiosurgery).

Related Articles

Signalling Pathway Alterations in Pituitary Adenomas: Involvement of Gsalpha, cAMP and Mitogen-Activated Protein Kinases
Journal of Neuroendocrinology, 11/03/09    Relevance Score: 68%

Regulation of Pituitary Function by Cytokines
Hormone Research, 10/27/09    Relevance Score: 67%

Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer
Pituitary, 10/29/09    Relevance Score: 66%

Pituitary metastasis of Merkel cell carcinoma
Journal of Neuro-Oncology, 10/28/09    Relevance Score: 66%

Predicting Recurrence of Nonfunctioning Pituitary Adenomas
Journal of Clinical Endocrinology and Metabolism, 10/15/09    Relevance Score: 66%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address